Aboubacar A. Soumah

Paris, 75019, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Treatment of mpox with tecovirimat under expanded access use in the Central African Republic.

Treatment of mpox with tecovirimat under expanded access use in the Central African Republic.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: April 03, 2026

Strengthening Africa's resilience to Mpox: Preparedness and response initiatives of the Pasteur network.

Strengthening Africa's resilience to Mpox: Preparedness and response initiatives of the Pasteur network.

Journal: Journal of public health in Africa

Published: November 28, 2024

Genomic epidemiology of clade Ia monkeypox viruses circulating in the Central African Republic in 2022-24: a retrospective cross-sectional study.

Genomic epidemiology of clade Ia monkeypox viruses circulating in the Central African Republic in 2022-24: a retrospective cross-sectional study.

Journal: The Lancet. Microbe

Published: November 19, 2024

Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the Congo.

Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the Congo.

Journal: Vaccines

Published: May 25, 2024

Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in Guinea.

Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in Guinea.

Journal: Vaccine

Published: February 09, 2020

Field investigation with real-time virus genetic characterisation support of a cluster of Ebola virus disease cases in Dubréka, Guinea, April to June 2015.

Field investigation with real-time virus genetic characterisation support of a cluster of Ebola virus disease cases in Dubréka, Guinea, April to June 2015.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: March 29, 2018

Safety of the rVSV ZEBOV vaccine against Ebola Zaire among frontline workers in Guinea.

Safety of the rVSV ZEBOV vaccine against Ebola Zaire among frontline workers in Guinea.

Journal: Vaccine

Published: March 02, 2017

Factors influencing participation in an Ebola vaccine trial among front-line workers in Guinea.

Factors influencing participation in an Ebola vaccine trial among front-line workers in Guinea.

Journal: Vaccine

Published: March 02, 2017

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).

Journal: Lancet (London, England)

Published: October 10, 2016

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.

Journal: Lancet (London, England)

Published: August 08, 2015

Showing 1-10 of 10

Last Updated: 09/26/2026